These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32203145)

  • 1. Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function.
    Nagate Y; Ezoe S; Fujita J; Okuzaki D; Motooka D; Ishibashi T; Ichii M; Tanimura A; Kurashige M; Morii E; Fukushima T; Suehiro Y; Yokota T; Shibayama H; Oritani K; Kanakura Y
    Leukemia; 2021 Jan; 35(1):107-118. PubMed ID: 32203145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
    Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
    J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD39+ regulatory T cells attenuate allergic airway inflammation.
    Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
    Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.
    Schuler PJ; Saze Z; Hong CS; Muller L; Gillespie DG; Cheng D; Harasymczuk M; Mandapathil M; Lang S; Jackson EK; Whiteside TL
    Clin Exp Immunol; 2014 Aug; 177(2):531-43. PubMed ID: 24749746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer.
    Bareche Y; Pommey S; Carneiro M; Buisseret L; Cousineau I; Thebault P; Chrobak P; Communal L; Allard D; Robson SC; Mes-Masson AM; Provencher D; Lapointe R; Stagg J
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33771891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsets.
    Cortés-Garcia JD; López-López C; Cortez-Espinosa N; García-Hernández MH; Guzmán-Flores JM; Layseca-Espinosa E; Portales-Cervantes L; Portales-Pérez DP
    Immunobiology; 2016 Jan; 221(1):84-93. PubMed ID: 26307000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
    Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
    Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
    Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
    Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 and IL-4 activate a CD39-dependent intrinsic peripheral tolerance mechanism in CD8(+) T cells.
    Noble A; Mehta H; Lovell A; Papaioannou E; Fairbanks L
    Eur J Immunol; 2016 Jun; 46(6):1438-48. PubMed ID: 26990545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
    Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
    Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
    Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation.
    Rissiek A; Baumann I; Cuapio A; Mautner A; Kolster M; Arck PC; Dodge-Khatami A; Mittrücker HW; Koch-Nolte F; Haag F; Tolosa E
    J Autoimmun; 2015 Apr; 58():12-20. PubMed ID: 25640206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain.
    Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H
    PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
    Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.
    Sun X; Wu Y; Gao W; Enjyoji K; Csizmadia E; Müller CE; Murakami T; Robson SC
    Gastroenterology; 2010 Sep; 139(3):1030-40. PubMed ID: 20546740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.
    Kaku H; Cheng KF; Al-Abed Y; Rothstein TL
    J Immunol; 2014 Dec; 193(12):5904-13. PubMed ID: 25392527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD39 Regulation and Functions in T Cells.
    Timperi E; Barnaba V
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways.
    Giatromanolaki A; Kouroupi M; Pouliliou S; Mitrakas A; Hasan F; Pappa A; Koukourakis MI
    Life Sci; 2020 Oct; 259():118389. PubMed ID: 32898522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8
    Canale FP; Ramello MC; Núñez N; Araujo Furlan CL; Bossio SN; Gorosito Serrán M; Tosello Boari J; Del Castillo A; Ledesma M; Sedlik C; Piaggio E; Gruppi A; Acosta Rodríguez EA; Montes CL
    Cancer Res; 2018 Jan; 78(1):115-128. PubMed ID: 29066514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia.
    Perry C; Hazan-Halevy I; Kay S; Cipok M; Grisaru D; Deutsch V; Polliack A; Naparstek E; Herishanu Y
    Ann Hematol; 2012 Aug; 91(8):1271-9. PubMed ID: 22349724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.